Literature DB >> 33531918

Efficacy and Safety of Sahastara Remedy Extract Capsule in Primary Knee Osteoarthritis: A Randomized Double-Blinded Active-Controlled Trial.

Narin Kakatum1, Piya Pinsornsak2, Puritat Kanokkangsadal3,4, Buncha Ooraikul5, Arunporn Itharat3,4.   

Abstract

Sahastara (SHT) remedy is a Thai traditional medicine described in the Thai National List of Essential Medicine (NLEM) for the relief of muscle pain. The purpose of this study was to investigate the efficacy and safety of SHT remedy extract capsule for treating primary OA. A phase 2, double-blind, randomized, and controlled trial study was used to determine the clinical efficacy and safety of SHT in comparison with diclofenac for the treatment of knee OA. The outcome of reduce pain was measured from VAS, 100 meter time walk, and the WOMAC score of day 14 and day 28 which should reduce significantly when compared with day 0 and should be equal with or better than diclofenac. Blood pressure and blood chemistry values at day 14 and day 28 did not change when compared with day 0. The results found that SHT remedy ethanolic extract capsule can reduce all OA knee scores at day 14 and day 28 significantly when compared with day 0 and also no significant difference with diclofenac (P > 0.05). The SHT also showed safety values on blood pressure and blood chemistry. The SHT was observed that it had no serious side effect. The results of this study are the first report of using the SHT ethanolic extract capsule in the treatment of primary osteoarthritis of the knee. It can be recommended as an anti-inflammatory herbal drug for reducing pain in knee osteoarthritis patients.
Copyright © 2021 Narin Kakatum et al.

Entities:  

Year:  2021        PMID: 33531918      PMCID: PMC7834797          DOI: 10.1155/2021/6635148

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  6 in total

Review 1.  A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms.

Authors:  Sylvain Mathieu; Martin Soubrier; Cedric Peirs; Laurent-Emmanuel Monfoulet; Yves Boirie; Anne Tournadre
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

2.  Prospective, Multicenter Evaluation of a Polyherbal Supplement alongside Standard-of-Care Treatment for Mild Knee Osteoarthritis.

Authors:  Zbigniew Żęgota; Joanna Goździk; Joanna Głogowska-Szeląg
Journal:  Adv Orthop       Date:  2021-05-07

3.  Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

Authors:  Mir Sadat-Ali; Abdallah S AlOmran; Sulaiman A AlMousa; Hasan N AlSayed; Khalid W AlTabash; Mohammed Q Azam; Tarek M Hegazi; Sadananda Acharya
Journal:  Adv Orthop       Date:  2021-11-20

4.  The Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis: A Randomized Active-Controlled Clinical Trial.

Authors:  Hamid Reza Farpour; Najme Rajabi; Bahareh Ebrahimi
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

5.  Development and optimization of Benjakul microemulsion formulations for enhancing topical anti-inflammatory effect and delivery.

Authors:  Pranporn Kuropakornpong; Arunporn Itharat; Buncha Ooraikul; Raimar Loebenberg; Neal M Davies
Journal:  Res Pharm Sci       Date:  2022-01-15

6.  The Efficacy of Backward Walking on Static Stability, Proprioception, Pain, and Physical Function of Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

Authors:  Zehua Chen; Xiangling Ye; Yi Wang; Zhen Shen; Jiatao Wu; Weijian Chen; Tao Jiang; Huai Wu; Xuemeng Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-11       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.